Published in Nutr Clin Pract on October 13, 2008
Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch-anal anastomosis: a case-matched study. Surg Endosc (2010) 1.53
Energy metabolism in Japanese patients with Crohn's disease. J Clin Biochem Nutr (2009) 0.97
Body mass index influences the response to infliximab in ankylosing spondylitis. Arthritis Res Ther (2012) 0.94
Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment. Inflamm Bowel Dis (2014) 0.86
Changes of energy metabolism, nutritional status and serum cytokine levels in patients with Crohn's disease after anti-tumor necrosis factor-α therapy. J Clin Biochem Nutr (2013) 0.84
Maintaining adequate nutrition, not probiotic administration, prevents growth stunting and maintains skeletal muscle protein synthesis rates in a piglet model of colitis. Pediatr Res (2010) 0.79
Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis. Scand J Gastroenterol (2016) 0.77
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet (2002) 14.14
A simple index of Crohn's-disease activity. Lancet (1980) 11.12
A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology (1989) 4.27
Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr (1998) 2.35
Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine). Gastroenterology (1973) 2.03
Iron, anaemia, and inflammatory bowel diseases. Gut (2004) 2.03
Factors influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine. Am J Clin Nutr (2005) 1.90
Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology (2000) 1.67
Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology (2003) 1.57
Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer (2002) 1.55
Nutrition assessment in the 1990s: where are we now? Nutr Clin Pract (1995) 1.41
Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol (1991) 1.40
Chronic inflammatory bowel disease and cancer. Hepatogastroenterology (2000) 1.32
Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol (1991) 1.29
A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res (1985) 1.18
Infliximab in Crohn's disease: first anniversary clinical experience. Am J Gastroenterol (2000) 1.14
Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther (2003) 1.11
Multiple vitamin status in Crohn's disease. Correlation with disease activity. Dig Dis Sci (1993) 1.11
Resting and total energy expenditure in patients with inflammatory bowel disease. Am J Clin Nutr (1991) 1.06
Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol (2007) 1.03
Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity. Int J Obes Relat Metab Disord (2000) 1.02
Energy and substrate metabolism in patients with active Crohn's disease. J Nutr (1999) 1.01
Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr (2000) 0.96
In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis. Gut (2000) 0.94
Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol (2000) 0.94
Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition (2000) 0.93
Protein and energy metabolism response to the initial dose of infliximab in children with Crohn's disease. Inflamm Bowel Dis (2007) 0.88
Assessment of nutritional status in Crohn's disease in remission or low activity. Hepatogastroenterology (1984) 0.87
Usefulness of the prognostic inflammatory and nutritional index (PINI) in hospitalized elderly patients. Int J Vitam Nutr Res (1998) 0.85
The prognostic value of nutritional and inflammatory indices in critically ill patients with acute respiratory failure. Clin Chem Lab Med (2002) 0.85
The cancer anorexia-cachexia syndrome: a survey of the Prognostic Inflammatory and Nutritional Index (PINI) in advanced disease. J Pain Symptom Manage (2002) 0.79
Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients. Hemodial Int (2005) 0.78
Body composition changes in cachectic patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr (2002) 0.78
The effect of severe undernutrition and subsequent refeeding on whole-body metabolism and protein synthesis in human subjects. JPEN J Parenter Enteral Nutr (2005) 0.77
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol (2010) 2.74
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc (2006) 2.73
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology (2007) 2.55
Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg (2008) 2.29
Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol (2006) 1.87
Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol (2005) 1.10
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Inflamm Bowel Dis (2012) 1.08
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis. Gastroenterology (2010) 1.04
Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol (2005) 0.93
Hospital readmissions in patients with inflammatory bowel disease. Am J Gastroenterol (2013) 0.91
A case of hypokalemia and rhabdomyolysis in a patient with short bowel syndrome. JPEN J Parenter Enteral Nutr (2003) 0.90
Retracted Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications. Am J Gastroenterol (2011) 0.88
Risk factors for clinical phenotypes of Crohn's disease of the ileal pouch. Am J Gastroenterol (2006) 0.87
Indicators of clinical response to treatment with six-mercaptopurine or azathioprine in patients with inflammatory bowel disease. Inflamm Bowel Dis (2004) 0.81
Hypocaloric home parenteral nutrition and nutrition parameters in patients following bariatric surgery. Nutr Clin Pract (2011) 0.80
Small bowel feeding tube placement using an electromagnetic tube placement device: accuracy of tip location. JPEN J Parenter Enteral Nutr (2011) 0.80
Diagnosis and treatment of ileal pouch diseases in patients with underlying ulcerative colitis. Curr Treat Options Gastroenterol (2006) 0.79
Can we immunogenotypically and immunophenotypically profile patients who are at risk for pouchitis? Am J Gastroenterol (2004) 0.78
Random versus targeted biopsies for colorectal cancer surveillance in inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2010) 0.77
2005 American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Standards and Guidelines survey. Nutr Clin Pract (2006) 0.77
Chemoprevention of colorectal cancer: slow, steady progress. Cleve Clin J Med (2003) 0.75
Quality commitment: the newly established American College of Gastroenterology Quality Council to meet the needs of clinical gastroenterology. Am J Gastroenterol (2013) 0.75
Managing short bowel syndrome: making the most of what the patient still has. Cleve Clin J Med (2005) 0.75
Continuing Medical Education Questions: October 2015. Am J Gastroenterol (2015) 0.75
A case of refractory diarrhea. Cleve Clin J Med (2008) 0.75
Maintaining normal blood glucose concentrations with total parenteral nutrition: is it necessary to taper total parenteral nutrition? Nutr Clin Pract (2003) 0.75
Antiviral Treatment for Colonic Cytomegalovirus Infection in Ulcerative Colitis Patients Significantly Improved Their Surgery Free Survival. J Clin Gastroenterol (2016) 0.75
Our Vision for the Future of Inflammatory Bowel Diseases: Research, Innovations, and Controversies. Inflamm Bowel Dis (2017) 0.75
Examination of factors that lead to complications for new home parenteral nutrition patients. J Infus Nurs (2006) 0.75
Continuing Medical Education Questions: October 2015. Am J Gastroenterol (2015) 0.75